• 代谢综合征和新陈代谢健康型肥胖症在欧洲的患病率 :十个队列研究的协同分析 (Chinese abstract) 

        Author(s):van Vliet-Ostaptchouk, JV; Nuotio, ML; Slagter, SN; Doiron, D; Fischer, K; Foco, L; Gaye, A; Gӧgele, M; Heier, M; Hiekkalinna, T; Joensuu, A; Newby, C; Pang, C; Partinen, E; Reischl, E; Schwienbacher, C; Tammesoo, ML; Swertz, MA; Burton, P; Ferretti, V; Fortier, I; Giepmans, L; Harris, JR; Hillege, HL; Holmen, J; Jula, A; Kootstra-Ros, JE; Kvaløy, K; Holmen, TL; Männistö, S; Metspalu, A; Midthjell, K; Murtagh, MJ; Peters, A; Pramstaller, PP; Saaristo, T; Salomaa, V; Stolk, RP; Uusitupa, M; van der Harst, P; van der Klauw, MM; Waldenberger, M; Perola, M; Wolffenbuttel, BH
        Date:2014-02-01
        欧洲人肥胖心血管疾病代谢综合征摘要背景:并非所有肥胖受试者都有不利的代谢特征,使其容易发展为2型糖尿病或心血管疾病。BioSHaRE-EU健康肥胖项目旨在通过在几个大型队列研究中取得的关于风险因素和表型的数据,了解(健康型)肥胖症的后果。本究的目的是通过10个参与研究得出肥胖症、代谢综合征(MetS)和新陈代谢健康型肥胖症(MHO)的患病率。方法:使用已转化为统一格式的数据将七个国家的10个不同研究组结合起来。所有参加者均为欧洲血统,年 ...
      • Prévalence du syndrome métabolique et l'obésitémétaboliquement saine en Europe : analyse collaborativede dix grandes études de cohort (French abstract), La 

        Author(s):van Vliet-Ostaptchouk, JV; Nuotio, ML; Slagter, SN; Doiron, D; Fischer, K; Foco, L; Gaye, A; Gӧgele, M; Heier, M; Hiekkalinna, T; Joensuu, A; Newby, C; Pang, C; Partinen, E; Reischl, E; Schwienbacher, C; Tammesoo, ML; Swertz, MA; Burton, P; Ferretti, V; Fortier, I; Giepmans, L; Harris, JR; Hillege, HL; Holmen, J; Jula, A; Kootstra-Ros, JE; Kvaløy, K; Holmen, TL; Männistö, S; Metspalu, A; Midthjell, K; Murtagh, MJ; Peters, A; Pramstaller, PP; Saaristo, T; Salomaa, V; Stolk, RP; Uusitupa, M; van der Harst, P; van der Klauw, MM; Waldenberger, M; Perola, M; Wolffenbuttel, BH
        Date:2014-02-01
        Résumé CONTEXTE : Tous les sujets obèses n'ont pas un profil métabolique à risques qui lesprédispose à développer un diabète de type 2 ou une maladiecardiovasculaire. Le projet BioSHaRE-EU Healthy Obese Project cherche ...
      • The prevalence of metabolic syndrome and metabolically healthy obesity in Europe : collaborative analysis of ten large cohort studies 

        Author(s):van Vliet-Ostaptchouk, JV; Nuotio, ML; Slagter, SN; Doiron, D; Fischer, K; Foco, L; Gaye, A; Gӧgele, M; Heier, M; Hiekkalinna, T; Joensuu, A; Newby, C; Pang, C; Partinen, E; Reischl, E; Schwienbacher, C; Tammesoo, ML; Swertz, MA; Burton, P; Ferretti, V; Fortier, I; Giepmans, L; Harris, JR; Hillege, HL; Holmen, J; Jula, A; Kootstra-Ros, JE; Kvaløy, K; Holmen, TL; Männistö, S; Metspalu, A; Midthjell, K; Murtagh, MJ; Peters, A; Pramstaller, PP; Saaristo, T; Salomaa, V; Stolk, RP; Uusitupa, M; van der Harst, P; van der Klauw, MM; Waldenberger, M; Perola, M; Wolffenbuttel, BH
        Date:2014-02-01
        BACKGROUND: Not all obese subjects have an adverse metabolic profile predisposing them to developing type 2 diabetes or cardiovascular disease. The BioSHaRE-EU Healthy Obese Project aims to gain insights into the consequences ...